New method for quickly testing how bacteria respond to antibiotics
Exclusive liquid repellency enables next-generation phenotypic antimicrobial susceptibility testing
['FUNDING_R01'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-11095992
This study is working on a faster way to test how well antibiotics can fight bacteria in patients, like those with infections in their blood or urine, so doctors can quickly find the right treatment for you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-11095992 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new system for antimicrobial susceptibility testing (AST) that can rapidly identify how bacteria from patients respond to antibiotics. By using an innovative liquid repellency technique, the study aims to streamline the testing process, allowing for quicker and more accurate results without the need for lengthy culture methods. This approach will directly test clinical samples, such as blood or urine, to provide timely treatment options for patients with bacterial infections. The research involves a collaborative team of experts from various fields, including microbiology and bioengineering.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with bacterial infections who require timely and accurate antibiotic susceptibility testing.
Not a fit: Patients with viral infections or those who do not have a bacterial infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective treatment options for patients with bacterial infections, reducing the risk of antibiotic resistance.
How similar studies have performed: Previous research has shown promise in improving antimicrobial susceptibility testing methods, but this specific approach using exclusive liquid repellency is novel.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROSE, WARREN E — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: ROSE, WARREN E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: bacteria infection, bacterial disease, Bacterial Infections